Results from the phase II ROME trial showed that patients with advanced solid tumors experienced significantly improved survival outcomes after receiving a tailored therapy based on the detection of t...
Researchers combined spatial transcriptomics with machine learning to develop a urine-based prostate cancer test with 92% accuracy, outperforming traditional PSA testing.